Midodrine Hydrochloride
NDC 51079-453, midodrine hydrochloride, tablet, from Mylan Institutional Inc..
- Product NDC
- 51079-453
- Status
- Listed
- Labeler
- Mylan Institutional Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076577
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51079-453 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIDODRINE HYDROCHLORIDE5 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51079-453-20 | 51079045320 | 100 BLISTER PACK in 1 CARTON (51079-453-20) / 1 TABLET in 1 BLISTER PACK (51079-453-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fd28d383-add9-42a9-ad07-4d7e89f12460NADAC price for package 51079045320
GET /v1/drugs/nadac/51079045320
Use it
Look up 51079-453 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51079-453 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51079-453. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.